These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 15655780)

  • 41. Intradermal or Sublingual Delivery and Heat-Labile Enterotoxin Proteins Shape Immunologic Responses to a CFA/I Fimbria-Derived Subunit Antigen Vaccine against Enterotoxigenic Escherichia coli.
    Maciel M; Bauer D; Baudier RL; Bitoun J; Clements JD; Poole ST; Smith MA; Kaminski RW; Savarino SJ; Norton EB
    Infect Immun; 2019 Nov; 87(11):. PubMed ID: 31427449
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli.
    Yu J; Cassels F; Scharton-Kersten T; Hammond SA; Hartman A; Angov E; Corthésy B; Alving C; Glenn G
    Infect Immun; 2002 Mar; 70(3):1056-68. PubMed ID: 11854183
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intestinal and systemic inflammation induced by symptomatic and asymptomatic enterotoxigenic
    Brubaker J; Zhang X; Bourgeois AL; Harro C; Sack DA; Chakraborty S
    Gut Microbes; 2021; 13(1):1-13. PubMed ID: 33645430
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteers.
    Carpenter CM; Hall ER; Randall R; McKenzie R; Cassels F; Diaz N; Thomas N; Bedford P; Darsley M; Gewert C; Howard C; Sack RB; Sack DA; Chang HS; Gomes G; Bourgeois AL
    Vaccine; 2006 May; 24(18):3709-18. PubMed ID: 16153753
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term systemic and mucosal antibody responses measured in BALB/c mice following intranasal challenge with viable enterotoxigenic Escherichia coli.
    Byrd W; Cassels FJ
    FEMS Immunol Med Microbiol; 2006 Mar; 46(2):262-8. PubMed ID: 16487308
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibodies induced by enterotoxigenic Escherichia coli (ETEC) adhesin major structural subunit and minor tip adhesin subunit equivalently inhibit bacteria adherence in vitro.
    Seo H; Nandre RM; Nietfeld J; Chen Z; Duan Q; Zhang W
    PLoS One; 2019; 14(5):e0216076. PubMed ID: 31042746
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh.
    Qadri F; Saha A; Ahmed T; Al Tarique A; Begum YA; Svennerholm AM
    Infect Immun; 2007 Aug; 75(8):3961-8. PubMed ID: 17548483
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Age-specific prevalence of antibody to enterotoxigenic Escherichia coli in Ecuadorian and German children.
    Brüssow H; Sidoti J; Link H; Hoang YK; Barclay D; Dirren H; Freire WB
    J Infect Dis; 1990 Oct; 162(4):974-7. PubMed ID: 2205656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyperimmune Bovine Colostral Anti-CS17 Antibodies Protect Against Enterotoxigenic Escherichia coli Diarrhea in a Randomized, Doubled-Blind, Placebo-Controlled Human Infection Model.
    Savarino SJ; McKenzie R; Tribble DR; Porter CK; O'Dowd A; Sincock SA; Poole ST; DeNearing B; Woods CM; Kim H; Grahek SL; Brinkley C; Crabb JH; Bourgeois AL
    J Infect Dis; 2019 Jul; 220(3):505-513. PubMed ID: 30897198
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of enterotoxigenic Escherichia coli isolated from U.S. troops deployed to the Middle East.
    Wolf MK; Taylor DN; Boedeker EC; Hyams KC; Maneval DR; Levine MM; Tamura K; Wilson RA; Echeverria P
    J Clin Microbiol; 1993 Apr; 31(4):851-6. PubMed ID: 8463396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Chimeric protein of CFA/I, CS6 subunits and LTB/STa toxoid protects immunized mice against enterotoxigenic Escherichia coli.
    Zeinalzadeh N; Salmanian AH; Goujani G; Amani J; Ahangari G; Akhavian A; Jafari M
    Microbiol Immunol; 2017 Jul; 61(7):272-279. PubMed ID: 28543534
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli.
    Koprowski H; Levine MM; Anderson RJ; Losonsky G; Pizza M; Barry EM
    Infect Immun; 2000 Sep; 68(9):4884-92. PubMed ID: 10948101
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomized clinical trial assessing the safety and immunogenicity of oral microencapsulated enterotoxigenic Escherichia coli surface antigen 6 with or without heat-labile enterotoxin with mutation R192G.
    Lapa JA; Sincock SA; Ananthakrishnan M; Porter CK; Cassels FJ; Brinkley C; Hall ER; van Hamont J; Gramling JD; Carpenter CM; Baqar S; Tribble DR
    Clin Vaccine Immunol; 2008 Aug; 15(8):1222-8. PubMed ID: 18579693
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Escherichia coli K88ac fimbriae expressing heat-labile and heat-stable (STa) toxin epitopes elicit antibodies that neutralize cholera toxin and STa toxin and inhibit adherence of K88ac fimbrial E. coli.
    Zhang C; Zhang W
    Clin Vaccine Immunol; 2010 Dec; 17(12):1859-67. PubMed ID: 20980482
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mucosal and systemic immune responses in patients with diarrhea due to CS6-expressing enterotoxigenic Escherichia coli.
    Qadri F; Ahmed T; Ahmed F; Bhuiyan MS; Mostofa MG; Cassels FJ; Helander A; Svennerholm AM
    Infect Immun; 2007 May; 75(5):2269-74. PubMed ID: 17296752
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli.
    Wolf MK
    Clin Microbiol Rev; 1997 Oct; 10(4):569-84. PubMed ID: 9336662
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Over-expression of major colonization factors of enterotoxigenic Escherichia coli, alone or together, on non-toxigenic E. coli bacteria.
    Tobias J; Holmgren J; Hellman M; Nygren E; Lebens M; Svennerholm AM
    Vaccine; 2010 Oct; 28(43):6977-84. PubMed ID: 20728524
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adhesion of enterotoxigenic Escherichia coli in humans and animals.
    Levine MM
    Ciba Found Symp; 1981; 80():142-60. PubMed ID: 6114818
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluating the A-Subunit of the Heat-Labile Toxin (LT) As an Immunogen and a Protective Antigen Against Enterotoxigenic Escherichia coli (ETEC).
    Norton EB; Branco LM; Clements JD
    PLoS One; 2015; 10(8):e0136302. PubMed ID: 26305793
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of transcutaneous immunization as a delivery route for an enterotoxigenic E. coli adhesin-based vaccine with CfaE, the colonization factor antigen 1 (CFA/I) tip adhesin.
    Rollenhagen JE; Woods CM; O'Dowd A; Poole ST; Tian JH; Guebre-Xabier M; Ellingsworth L; Prouty MG; Glenn G; Savarino SJ
    Vaccine; 2019 Sep; 37(42):6134-6138. PubMed ID: 31492474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.